Opinion|Videos|June 27, 2024
Strategies to Increase Biomarker Testing Rates
Key opinion leaders provide insight to providing biomarker testing within and beyond guideline recommendations.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What strategies can help ensure all appropriate mNSCLC patients receive comprehensive biomarker testing in line with guidelines?
- What are community-based best practices, and what are academic-based practices?
- Despite the guidelines, what gaps exist between recommended biomarker testing rates and real-world testing utilization?
Advertisement
Related to this article
Medicare drug price negotiations lowered out-of-pocket costs for some beneficiaries, but those reaching the annual Part D cap saw no direct savings.
AI quantitative CT (UCLA QILD, Brainomix e-Lung) predicts FVC decline and drug response in PPF, strengthening biomarkers beyond spirometry in INBUILD.
Delphi consensus guides dermatology on spotting CTCL vs atopic dermatitis before/after dupilumab, using biopsy plus T-cell clonality testing and safer treatment switches.
Rosacea is likely missed, not rare, in skin of color, as low suspicion and hard-to-see redness delay diagnosis, said Hilary Baldwin, MD.
Hidradenitis suppurativa diagnosis often takes 7 to 10 years, and patients with skin of color often present with tunnels and scarring already in place.
In HIV, lymphoma survival tracks tumor stage and CD4 count, not viral suppression, a Spanish cohort shows.
Polyphenols show lab promise for endometriosis, but human evidence is thin, and the best resveratrol pain trial was negative.
Those using e-cigarettes were more likely to develop cataracts, and those receiving cataract surgery less likely to develop depression and anxiety.
Advertisement
Advertisement
Trending on AJMC
1
A New Mechanism for DME in the BRUNELLO Trial: Donald J. D’Amico, MD
2
Using Complement Inhibitors in GA Comes With Pros and Cons
3
Medicare Drug Price Negotiations Yield Uneven Out-of-Pocket Savings
4
New Mechanism of DME Treatment Highlights Clinical Trial Updates
5